The use of innovative gadolinium-based contrast agent for MR-diagnosis of cancer in the experiment

The use of innovative gadolinium-based contrast agent for MR-diagnosis of cancer in the experiment

Bibliographic Details
Parent link:Journal of Physics: Conference Series
Vol. 677 : Magnetic resonance imaging in biomedical research.— 2016.— [012009, 7 p.]
Corporate Author: Национальный исследовательский Томский политехнический университет Инженерная школа неразрушающего контроля и безопасности Отделение электронной инженерии
Other Authors: Chernov V. I. Vladimir Ivanovich, Medvedeva А. А. Anna Aleksndrovna, Sinilkin I. G. Ivan Gennadjevich, Zelchan R. V. Roman Vladimirovich, Grigorev E. G., Frolova I. G., Nam I. F. Irina Feliksovna
Summary:Title screen
The present study of the functional suitability and specific activity of the contrast agent gadolinium-based for magnetic resonance imaging demonstrated that the investigated contrast agent intensively accumulates in organs and anatomical structures of the experimental animals. In the model of tumor lesions in animals, study have shown that investigational contrast agent accumulates in the tumor tissue and retained there in for a long enough time.
Published: 2016
Subjects:
электронный ресурс
труды учёных ТПУ
контрастные препараты
гадолиний
магнитно-резонансная томография
онкологические заболевания
Online Access:https://doi.org/10.1088/1742-6596/677/1/012009
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=657807

Similar Items

Similar Items